The “Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period.
The rapid growth in the newborn screening rate, the increasing prevalence of newborn metabolic, hormonal and genetic diseases, and favourable government policies are driving the growth of newborn screening.
Newborn Disorder screening instruments segment accounted for the largest share of the newborn screening market in 2019.
Based on instrument, the newborn screening market is segmented into newborn disorder screening instruments, newborn hearing screening instruments, and pulse oximeters. Newborn disorder screening instruments accounted for the largest share in 2019. These instruments can screen for the majority of newborn disorders and thus see the highest demand. Government support and the implementation of newborn screening programs also support the market.
Dry blood spot tests accounted for the largest share of the newborn screening market in 2019.
The newborn screening market, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.
Asia Pacific estimated to register the highest CAGR during the forecast period.
In this report, the newborn screening market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of newborn, increasing prevalence of newborn disorders, increasing awareness about early diagnosis of disease, and rising focus of key players in this region.
- Rising Prevalence of Newborn Disorders
- Newborn Screening Programs and Legislation
- Favorable Reimbursement Policies
- Growth Potential of Emerging Economies
- Availability of Refurbished Products
- Ab Sciex
- Bio-Rad Laboratories
- Chromsystems Instruments & Chemicals
- Drg International
- Intelligent Hearing Systems Corp.
- Mp Biomedicals
- Natus Medical
- Parseq Lab
- Recipe Chemicals + Instruments Gmbh
- Regis Technologies
- Thermo Fisher Scientific
- Trivitron Healthcare
- Waters Corporation
- Welch Allyn
- Zivak Technologies
For more information about this report visit https://www.researchandmarkets.com/r/m543sp
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900